139 related articles for article (PubMed ID: 1617708)
21. Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
Wall TC; Califf RM; George BS; Ellis SG; Samaha JK; Kereiakes DJ; Worley SJ; Sigmon K; Topol EJ
J Am Coll Cardiol; 1992 Mar; 19(3):482-9. PubMed ID: 1537998
[TBL] [Abstract][Full Text] [Related]
22. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
[TBL] [Abstract][Full Text] [Related]
23. Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency.
Meierhenrich R; Carlsson J; Seifried E; Pfarr E; Smolarz A; Neuhaus KL; Tebbe U
Int J Cardiol; 1998 Jun; 65(1):57-63. PubMed ID: 9699932
[TBL] [Abstract][Full Text] [Related]
24. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
[TBL] [Abstract][Full Text] [Related]
25. [Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)].
Gulba DC; Bode C; Topp J; Höpp HW; Westhoff-Bleck M; Rafflenbeul W; Lichtlen PR
Z Kardiol; 1990 Apr; 79(4):279-85. PubMed ID: 2113330
[TBL] [Abstract][Full Text] [Related]
26. Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction.
Collen D; Van de Werf F
Am J Cardiol; 1987 Sep; 60(7):431-4. PubMed ID: 3115077
[TBL] [Abstract][Full Text] [Related]
27. Time course of left ventricular function and coronary patency after saruplase vs streptokinase in acute myocardial infarction. The PRIMI Trial Study Group.
Schofer J; Lins M; Mathey DG; Sheehan FH
Eur Heart J; 1993 Jul; 14(7):958-63. PubMed ID: 8375422
[TBL] [Abstract][Full Text] [Related]
28. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
[TBL] [Abstract][Full Text] [Related]
29. A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial.
Ross AM; Gao R; Coyne KS; Chen J; Yao K; Yang Y; Qin X; Qiao S; Yao M;
Am Heart J; 2001 Aug; 142(2):244-7. PubMed ID: 11479462
[TBL] [Abstract][Full Text] [Related]
30. Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial.
Hartmann JR; McKeever LS; O'Neill WW; White CJ; Whitlow PL; Gilmore PS; Doorey AJ; Galichia JP; Enger EL
J Am Coll Cardiol; 1996 Jan; 27(1):60-6. PubMed ID: 8522711
[TBL] [Abstract][Full Text] [Related]
31. Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction.
von Hodenberg E; Kreuzer J; Hautmann M; Nordt T; Kübler W; Bode C
Am J Cardiol; 1991 Jun; 67(16):1349-53. PubMed ID: 1828324
[TBL] [Abstract][Full Text] [Related]
32. Fibrinolytic effects of pro-urokinase combined with low-dose urokinase compared to high-dose urokinase in patients with acute myocardial infarction.
Pindur G; Koehler M; Sen S; Hermes R; Miyashita C; Wenzel E; Schieffer H
Thromb Res; 1992 Jul; 67(2):191-200. PubMed ID: 1279835
[TBL] [Abstract][Full Text] [Related]
33. Clinical study on the thrombolytic effect with different doses of urokinase in acute myocardial infarction. The Collaborative Research Group on Thrombolysis.
Chin Med J (Engl); 1997 Jan; 110(1):43-6. PubMed ID: 9594320
[TBL] [Abstract][Full Text] [Related]
34. Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction.
Van de Werf F; Nobuhara M; Collen D
Ann Intern Med; 1986 Mar; 104(3):345-8. PubMed ID: 3080936
[TBL] [Abstract][Full Text] [Related]
35. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
[TBL] [Abstract][Full Text] [Related]
36. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
[TBL] [Abstract][Full Text] [Related]
37. [Initial experiences with pro-urokinase in acute myocardial infarct].
Schanzenbächer P; Huber J; Keller F; Kochsiek K
Z Kardiol; 1987 Sep; 76(9):570-5. PubMed ID: 3122430
[TBL] [Abstract][Full Text] [Related]
38. Comparison of double bolus urokinase versus front-loaded alteplase regimen for acute myocardial infarction. Thrombolysis in Myocardial Infarction in Korea (TIMIKO) study group.
Park SJ
Am J Cardiol; 1998 Sep; 82(6):811-3, A10. PubMed ID: 9761098
[TBL] [Abstract][Full Text] [Related]
39. [Pro-urokinase for infarct therapy].
Spiecker M; Meyer J
Herz; 1994 Dec; 19(6):326-35. PubMed ID: 7843689
[TBL] [Abstract][Full Text] [Related]
40. Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction.
Bär FW; Meyer J; Vermeer F; Michels R; Charbonnier B; Haerten K; Spiecker M; Macaya C; Hanssen M; Heras M; Boland JP; Morice MC; Dunn FG; Uebis R; Hamm C; Ayzenberg O; Strupp G; Withagen AJ; Klein W; Windeler J; Hopkins G; Barth H; von Fisenne MJ
Am J Cardiol; 1997 Mar; 79(6):727-32. PubMed ID: 9070549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
